PACS Group, Inc. (PACS)
Free
No email, no account, no signup.
Pulling latest news for PACS Group, Inc.…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report –
Order analysis – $4.99 $1.25
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NYSE
Sector
Post-acute healthcare services
Market Cap
$5.3B
Market sentiment
Sentiment has improved materially on the earnings/revenue beat, raised EBITDA guidance, and the buyback authorization; remaining concerns center on lumpiness from WQIP and some insider selling.
Why BUY ?
Raised full-year EBITDA guidance, strong operating cash flow, and the buyback improve the risk/reward and provide downside support, though part of Q1 strength reflects more volatile incentive payments.
- Consider adding in tranches (e.g., 1/3 now, 2/3 after Q2 confirmation), monitoring margins excluding WQIP and occupancy trends.
We're already tracking PACS Group, Inc. — here are the latest events we've registered
Recent News
- On May 11, 2026 PACS reported Q1-2026 results with $1.42B revenue and $80.7M net income, and $170.4M adjusted EBITDA (including about $16.3M of CA WQIP payments). The company raised FY adjusted EBITDA guidance to $605–625M and the board authorized a $250M share repurchase program. Co-founder/CFO Mark Hancock will retire June 30, 2026 with Carey P. Hendrickson appointed as the new CFO; the company also continues the Alaska acquisition and plans for a new skilled nursing facility.
Want to know how this news affects PACS Group, Inc.? Order the analysis.
Order analysis – Catalysts
30 Jun 2026 — CFO transition (Hancock retires, Hendrickson appointed)
Dilution Risk
Assessment: Low
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Sources: news, filings, market data, and investor forums
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of PACS Group, Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.